Published in Ann Nucl Med on September 01, 2003
Xanthines as adenosine receptor antagonists. Handb Exp Pharmacol (2011) 0.96
Quantification of adenosine A2A receptors in the human brain using [11C]TMSX and positron emission tomography. Eur J Nucl Med Mol Imaging (2006) 0.83
Test-retest variability of adenosine A2A binding in the human brain with (11)C-TMSX and PET. EJNMMI Res (2014) 0.77
Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab (2007) 11.79
Multimodal imaging of brain reorganization in motor areas of the contralesional hemisphere of well recovered patients after capsular stroke. Brain (2005) 2.03
Constraint-induced therapy in stroke: magnetic-stimulation motor maps and cerebral activation. Neurorehabil Neural Repair (2003) 1.83
Ferroelectricity from iron valence ordering in the charge-frustrated system LuFe2O4. Nature (2005) 1.83
Aortic wall inflammation due to Takayasu arteritis imaged with 18F-FDG PET coregistered with enhanced CT. J Nucl Med (2005) 1.70
Regional differences in blood flow and oxygen consumption in resting muscle and their relationship during recovery from exhaustive exercise. J Appl Physiol (1985) (2003) 1.53
Validation of cardiac (123)I-MIBG scintigraphy in patients with Parkinson's disease who were diagnosed with dopamine PET. Eur J Nucl Med Mol Imaging (2010) 1.51
Brief screening tool for mild cognitive impairment in older Japanese: validation of the Japanese version of the Montreal Cognitive Assessment. Geriatr Gerontol Int (2010) 1.44
¹¹C-PiB PET imaging of encephalopathy associated with cerebral amyloid angiopathy. Intern Med (2014) 1.41
Circulating thrombospondin-2 reflects disease severity and predicts outcome of heart failure with reduced ejection fraction. Circ J (2014) 1.41
Database of normal human cerebral blood flow, cerebral blood volume, cerebral oxygen extraction fraction and cerebral metabolic rate of oxygen measured by positron emission tomography with 15O-labelled carbon dioxide or water, carbon monoxide and oxygen: a multicentre study in Japan. Eur J Nucl Med Mol Imaging (2004) 1.36
Extraction of a plasma time-activity curve from dynamic brain PET images based on independent component analysis. IEEE Trans Biomed Eng (2005) 1.36
High occupancy of sigma-1 receptors in the human brain after single oral administration of fluvoxamine: a positron emission tomography study using [11C]SA4503. Biol Psychiatry (2007) 1.33
Effects of KTP laser irradiation, diode laser, and LED on tooth bleaching: a comparative study. Photomed Laser Surg (2007) 1.32
PET kinetic analysis--compartmental model. Ann Nucl Med (2006) 1.28
Expanding the clinical phenotype of SNCA duplication carriers. Mov Disord (2009) 1.25
Regional analysis of age-related decline in dopamine transporters and dopamine D2-like receptors in human striatum. Synapse (2009) 1.15
In vivo evaluation of P-glycoprotein modulation of 8 PET radioligands used clinically. J Nucl Med (2007) 1.09
High occupancy of sigma1 receptors in the human brain after single oral administration of donepezil: a positron emission tomography study using [11C]SA4503. Int J Neuropsychopharmacol (2009) 1.09
Usefulness of L-[methyl-11C] methionine-positron emission tomography as a biological monitoring tool in the treatment of glioma. J Neurosurg (2005) 1.09
Rasmussen syndrome: multifocal spread of inflammation suggested from MRI and PET findings. Epilepsia (2003) 1.08
Low density of sigma1 receptors in early Alzheimer's disease. Ann Nucl Med (2008) 1.07
Preclinical and the first clinical studies on [11C]CHIBA-1001 for mapping alpha7 nicotinic receptors by positron emission tomography. Ann Nucl Med (2009) 1.06
Evaluation of limiting brain penetration related to P-glycoprotein and breast cancer resistance protein using [(11)C]GF120918 by PET in mice. Mol Imaging Biol (2011) 1.06
Influence of mild hyperglycemia on cerebral FDG distribution patterns calculated by statistical parametric mapping. Ann Nucl Med (2008) 0.97
Micro-computed tomographic comparison of nickel-titanium rotary versus traditional instruments in C-shaped root canal system. J Endod (2010) 0.97
Glioma surgery using a multimodal navigation system with integrated metabolic images. J Neurosurg (2009) 0.96
Adenosine A(2A) receptors measured with [C]TMSX PET in the striata of Parkinson's disease patients. PLoS One (2011) 0.95
Morphological and microleakage studies of the cavities prepared by Er:YAG laser irradiation in primary teeth. J Clin Laser Med Surg (2002) 0.94
Photophobia in essential blepharospasm--a positron emission tomographic study. Mov Disord (2010) 0.94
A gait abnormality measure based on root mean square of trunk acceleration. J Neuroeng Rehabil (2013) 0.94
18F-FEAC and 18F-FEDAC: PET of the monkey brain and imaging of translocator protein (18 kDa) in the infarcted rat brain. J Nucl Med (2010) 0.94
PET imaging of lung inflammation with [18F]FEDAC, a radioligand for translocator protein (18 kDa). PLoS One (2012) 0.93
Omission of serial arterial blood sampling in neuroreceptor imaging with independent component analysis. Neuroimage (2005) 0.93
Synthesis and evaluation of novel radioligands for positron emission tomography imaging of metabotropic glutamate receptor subtype 1 (mGluR1) in rodent brain. J Med Chem (2012) 0.93
Greater adenosine A(2A) receptor densities in cardiac and skeletal muscle in endurance-trained men: a [11C]TMSX PET study. Nucl Med Biol (2005) 0.92
Morphological comparative study on ablation of dental hard tissues at cavity preparation by Er:YAG and Er,Cr:YSGG lasers. Photomed Laser Surg (2005) 0.91
Gait adaptability and brain activity during unaccustomed treadmill walking in healthy elderly females. Gait Posture (2012) 0.91
Radiosynthesis and preliminary evaluation of 4-[18F]fluoro-N-[4-[6-(isopropylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl]-N-methylbenzamide as a new positron emission tomography ligand for metabotropic glutamate receptor subtype 1. Bioorg Med Chem Lett (2011) 0.91
Regulated shedding of PAR1 N-terminal exodomain from endothelial cells. J Biol Chem (2004) 0.90
Posterior cortical atrophy with [11C] Pittsburgh compound B accumulation in the primary visual cortex. J Neurol (2010) 0.90
Efficacy of prophylactic treatment with montelukast and montelukast plus add-on loratadine for seasonal allergic rhinitis. Allergy Asthma Proc (2012) 0.90
Direct comparison of radiation dosimetry of six PET tracers using human whole-body imaging and murine biodistribution studies. Ann Nucl Med (2013) 0.90
Voxel- and ROI-based statistical analyses of PET parameters for guidance in the surgical treatment of intractable mesial temporal lobe epilepsy. Ann Nucl Med (2008) 0.89
Evaluation of distribution of adenosine A2A receptors in normal human brain measured with [11C]TMSX PET. Synapse (2007) 0.89
Glucose hypermetabolism in the thalamus of patients with essential blepharospasm. J Neurol (2007) 0.89
Quantification of deaminase activity-dependent and -independent restriction of HIV-1 replication mediated by APOBEC3F and APOBEC3G through experimental-mathematical investigation. J Virol (2014) 0.89
Whole-body distribution and brain tumor imaging with (11)C-4DST: a pilot study. J Nucl Med (2011) 0.89
Thermographical and morphological studies of Er,Cr:YSGG laser irradiation on root canal walls. Photomed Laser Surg (2004) 0.89
Clinical assessment of Er,Cr:YSGG laser application for cavity preparation. J Clin Laser Med Surg (2002) 0.88
Parkinsonism in type I Gaucher's disease. Intern Med (2006) 0.88
Initial human PET studies of metabotropic glutamate receptor type 1 ligand 11C-ITMM. J Nucl Med (2013) 0.88
Comparison of 18F-fluoromethylcholine and 2-deoxy-D-glucose in the distribution of tumor and inflammation. Ann Nucl Med (2006) 0.88
Imaging for metabotropic glutamate receptor subtype 1 in rat and monkey brains using PET with [18F]FITM. Eur J Nucl Med Mol Imaging (2011) 0.88
Quantitative evaluation of cerebral hemodynamics in patients with moyamoya disease by dynamic susceptibility contrast magnetic resonance imaging--comparison with positron emission tomography. J Cereb Blood Flow Metab (2006) 0.87
Translocator protein (18 kDa), a potential molecular imaging biomarker for non-invasively distinguishing non-alcoholic fatty liver disease. J Hepatol (2012) 0.87
Brain histamine H receptor occupancy of orally administered antihistamines measured by positron emission tomography with (11)C-doxepin in a placebo-controlled crossover study design in healthy subjects: a comparison of olopatadine and ketotifen. Br J Clin Pharmacol (2006) 0.87
Caries removal with Carisolv system: criteria evaluation and microleakage test. J Clin Pediatr Dent (2005) 0.87
Radiosynthesis and evaluation of [11C]YM-202074 as a PET ligand for imaging the metabotropic glutamate receptor type 1. Nucl Med Biol (2010) 0.87
Neuropathological asymmetry in argyrophilic grain disease. J Neuropathol Exp Neurol (2010) 0.87
Acquired acid resistance of enamel and dentin by CO2 laser irradiation with sodium fluoride solution. J Clin Laser Med Surg (2002) 0.86
The potential of (-)-o-[11C]methylvesamicol for diagnosing cholinergic deficit dementia. Synapse (2009) 0.86
[11C]Gefitinib ([11c]Iressa): radiosynthesis, in vitro uptake, and in vivo imaging of intact murine fibrosarcoma. Mol Imaging Biol (2009) 0.86
Amyloid β accumulation assessed with ¹¹C-Pittsburgh compound B PET and postmortem neuropathology. Curr Alzheimer Res (2015) 0.86
Visualization of early infarction in rat brain after ischemia using a translocator protein (18 kDa) PET ligand [11C]DAC with ultra-high specific activity. Neuroimage (2010) 0.86
Morphological changes of bovine mandibular bone irradiated by Er,Cr:YSGG laser: an in vitro study. J Clin Laser Med Surg (2002) 0.86
Usefulness of [11C]methionine PET in the diagnosis of dysembryoplastic neuroepithelial tumor with temporal lobe epilepsy. Epilepsia (2004) 0.86
Selective subtemporal amygdalohippocampectomy for refractory temporal lobe epilepsy: operative and neuropsychological outcomes. J Neurosurg (2007) 0.86